DWM
GILD icon

Dogwood Wealth Management’s Gilead Sciences GILD Stock Holding History

Dogwood Wealth Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$43K Sell
340
-50
-13% -$6.59K 0.02% 171
2026
Q1 		$54.4K Buy
390
+157
+67% +$22K 0.02% 140
2025
Q4 		$28.6K Buy
233
+14
+6% +$1.7K 0.01% 164
2025
Q3 		$24.3K Buy
219
+56
+34% +$6.37K 0.01% 168
2025
Q2 		$18.1K Buy
163
+98
+151% +$10.4K 0.01% 189
2025
Q1 		$7.28K Buy
+65
New +$6.71K ﹤0.01% 215
2024
Q3 		– Hold
0
– – – 230
2024
Q2 		– Hold
0
– – – 281
2024
Q1 		– Hold
0
– – – 278
2023
Q4 		– Hold
0
– – – 247

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Dogwood Wealth Management's GILD Position: Q2 2026 in Review

Dogwood Wealth Management reduced its Gilead Sciences (GILD) stake by 13% in Q2 2026, selling an estimated $6.59K and leaving 340 shares worth $43K. The position accounts for 0.02% of the portfolio, ranked #171.

Dogwood Wealth Management first reported a position in GILD in Q1 2025 and has held it in 6 quarters since. The position peaked at $54.4K in Q1 2026. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Dogwood Wealth Management held 340 shares of Gilead Sciences worth $43K as of Q2 2026.
  • Dogwood Wealth Management sold 50 Gilead Sciences shares in Q2 2026, an estimated $6.59K.
  • Gilead Sciences made up 0.02% of Dogwood Wealth Management's portfolio in Q2 2026, its #171 holding.
  • Dogwood Wealth Management first reported a position in Gilead Sciences in Q1 2025 and has held it in 6 quarters since.
  • Dogwood Wealth Management's Gilead Sciences position peaked at $54.4K in Q1 2026.
  • 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Dogwood Wealth Management's 13F filing for Q2 2026, filed 6 Jul 2026.